Evan Lee Salim

Pharma’s Aggressive 2026: A Multi-Billion Dollar M&A Resurgence pharmas-aggressive-2026-a-multi-billion-dollar-ma-resurgence

Evan Lee Salim May 9, 2026

The global pharmaceutical landscape is currently undergoing a transformative shift, marked by an aggressive return to dealmaking...

The Borderless Frontier: Navigating the High-Stakes Complexity of Global Pharmaceutical IP the-borderless-frontier-navigating-the-high-stakes-complexity-of-global-pharmaceutical-ip

Evan Lee Salim May 9, 2026

In the modern pharmaceutical landscape, the journey of a life-saving therapy is rarely a linear path contained...

The Intersection of Oncology and Motherhood: Navigating Fertility in the Wake of Breast Cancer the-intersection-of-oncology-and-motherhood-navigating-fertility-in-the-wake-of-breast-cancer

Evan Lee Salim May 8, 2026

The landscape of breast cancer is shifting. While historically viewed as a disease of older age, an...

Unmasking the Molecular Dance: New Imaging Technique Reveals the Secrets of Cancer-Driving Receptors unmasking-the-molecular-dance-new-imaging-technique-reveals-the-secrets-of-cancer-driving-receptors

Evan Lee Salim May 8, 2026

Introduction: A New Window into Cellular Chaos In the high-stakes world of oncology, few protein families are...

Entrada Therapeutics’ DMD Drug Falls Short of Investor Expectations, Stock Plummets Amidst Competitive Landscape entrada-therapeutics-dmd-drug-falls-short-of-investor-expectations-stock-plummets-amidst-competitive-landscape

Evan Lee Salim May 8, 2026

San Diego, CA – May 15, 2024 – Entrada Therapeutics, a biotechnology company focused on developing novel...

You may have missed